drugset / Trial / NCT00024284

Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors

NCT00024284 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of combining carboplatin and irinotecan in treating children who have refractory solid tumors.

Timeline

Start
2001-06
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Irinotecan Small molecule — Intravenous